In conclusion, we have demonstrated that LGR5 is expressed in the cytoplasm of pancreatic cancer cells and the basolateral membrane of endocrine cells of the pancreas in patients with PDA. This evidence concerns the gene LGR5 and Patent ductus arteriosus.